Nu Skin Enterprises (NYSE: NUS) reported Q4 EPS of $0.79, $0.01 worse than the analyst estimate of $0.80. Revenue for the quarter came in at $531.3 million versus the consensus estimate of $553.19 million.

The company also reiterated guidance provided at its 2016 investor day in December with anticipated revenue of $2.26 to $2.30 billion and earnings per share of $3.10 to $3.25, assuming a 3 to 4 percent negative foreign currency impact.

For earnings history and earnings-related data on Nu Skin Enterprises (NUS) click here.